0006-3066Level 3
EMEND (aprepitant)
**Product type:** Human Prescription Drug
**Active ingredient:** APREPITANT
**Strength:** 125 mg/1
**Dosage form:** Powder, For Suspension
**Route:** Oral
**Labeler:** Merck Sharp & Dohme LLC
**Marketing category:** NDA (NDA207865)
**Pharmacologic class:** Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC]
GET
/api/v1/systems/ndc_fda/nodes/0006-3066Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.